Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09DFB
|
|||
| Former ID |
DIB001277
|
|||
| Drug Name |
EFEGATRAN SULFATE HYDRATE
|
|||
| Synonyms |
Efegatran sulfate hydrate < Rec INNM; N-Methyl-D-phenylalanyl-L-prolyl-L-arginal sulfate hydrate; N-Methyl-D-phenylalanyl-N-[4-guanidino-1(S)-formylbutyl]-L-prolinamide sulfate hydrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H36N6O8S
|
|||
| Canonical SMILES |
CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O.O.OS(=O)(=O)O
|
|||
| InChI |
1S/C21H32N6O3.H2O4S.H2O/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23;1-5(2,3)4;/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25);(H2,1,2,3,4);1H2/t16-,17+,18-;;/m0../s1
|
|||
| InChIKey |
JJJFZLGPEFEADH-VWRRVXQQSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Efegatran. Institute for drug research/IVAX. IDrugs. 2001 Jun;4(6):691-4. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.